Wolverine Trading’s BIO-key International BKYI Stock Holding History

Wolverine Trading’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-107	Closed	-$46K	–	4523
2022 Q1	$46K	Buy	+107	New	+$43.2K	﹤0.01%	5097
2021 Q4	–	Sell	-73	Closed	-$45K	–	5889
2021 Q3	$45K	Buy	+73	New	+$43.1K	﹤0.01%	6034

Other funds holding BKYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wolverine Trading's BKYI Position: Q2 2022 in Review

Wolverine Trading sold out of BIO-key International (BKYI) in Q2 2022, closing a stake of 86 shares — an estimated $38K sold.

Wolverine Trading first reported a position in BKYI in Q2 2021 and held it in 3 quarters. The position peaked at $48K in Q2 2021. 8 funds tracked by Wall St. Rank hold BKYI as of Q2 2022.

Wolverine Trading reported no remaining BIO-key International position as of Q2 2022 after selling out during the quarter.
Wolverine Trading sold 86 BIO-key International shares in Q2 2022, an estimated $38K.
Wolverine Trading first reported a position in BIO-key International in Q2 2021 and held it in 3 quarters.
Wolverine Trading's BIO-key International position peaked at $48K in Q2 2021.
8 funds tracked by Wall St. Rank held BIO-key International as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.